28.03.2024 13:34:18 - dpa-AFX: *GILEAD : FDA EXPANDS INDICATION FOR VEMLIDY TO TREAT CHRONIC HBV INFECTION IN PEDIATRIC PATIENTS AS YOUNG AS SIX

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
GILEAD SCIENCES DL-,001 885823 Xetra 60,760 03.05.24 14:08:19 -0,130 -0,21% 60,720 61,030 60,700 60,890

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH